We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$82.6B
AUM Growth
+$5.37B
(+7%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,870
New
171
Increased
762
Reduced
655
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$461M |
| 2 |
TJX Companies
TJX
|
+$190M |
| 3 |
Amazon
AMZN
|
+$190M |
| 4 |
Franco-Nevada
FNV
|
+$184M |
| 5 |
Manulife Financial
MFC
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$265M |
| 2 |
MSCI
MSCI
|
+$196M |
| 3 |
Gartner
IT
|
+$170M |
| 4 |
Toronto Dominion Bank
TD
|
+$169M |
| 5 |
Amphenol
APH
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.2% |
| 2 | Financials | 21.24% |
| 3 | Industrials | 10.14% |
| 4 | Materials | 8.03% |
| 5 | Healthcare | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Concentrix
CNXC
$1.5B
| $962K | ﹤0.01% |
20,845
-989
| -5% | -$52.8K |
|
|
PLG
1077
Platinum Group Metals
PLG
$164M
| $961K | ﹤0.01% |
362,511
| – | – |
|
1078
Carlyle Group
CG
$16.6B
| $957K | ﹤0.01% |
+15,260
| New | +$953K |
|
1079
Sarepta Therapeutics
SRPT
$1.57B
| $955K | ﹤0.01% |
49,548
+20,616
| +71% | +$368K |
|
1080
Hims & Hers Health
HIMS
$6.43B
| $951K | ﹤0.01% |
16,775
-1,639
| -9% | -$84K |
|
|
CVSA
1081
Covista Inc
CVSA
$4.25B
| $943K | ﹤0.01% |
6,108
-10,923
| -64% | -$1.4M |
|
|
CRCL
1082
Circle Internet Group
CRCL
$15.6B
| $943K | ﹤0.01% |
+7,115
| New | +$1.13M |
|
1083
TORM
TRMD
$3.1B
| $939K | ﹤0.01% |
45,717
+9,540
| +26% | +$192K |
|
1084
International General Insurance
IGIC
$1.19B
| $937K | ﹤0.01% |
40,385
+2,355
| +6% | +$56.4K |
|
1085
World Kinect Corp
WKC
$2.04B
| $936K | ﹤0.01% |
36,061
+339
| +0.9% | +$9.13K |
|
1086
Puma Biotechnology
PBYI
$404M
| $930K | ﹤0.01% |
175,210
-32,381
| -16% | -$137K |
|
1087
Teladoc Health
TDOC
$1.22B
| $923K | ﹤0.01% |
119,460
-46,457
| -28% | -$363K |
|
1088
Barrett Business Services
BBSI
$959M
| $916K | ﹤0.01% |
20,679
-90
| -0.4% | -$4.12K |
|
1089
Oshkosh
OSK
$8.79B
| $916K | ﹤0.01% |
7,059
+2,467
| +54% | +$327K |
|
1090
Atara Biotherapeutics
ATRA
$75.5M
| $914K | ﹤0.01% |
63,816
+41,302
| +183% | +$475K |
|
1091
TripAdvisor
TRIP
$1.65B
| $911K | ﹤0.01% |
+56,002
| New | +$977K |
|
1092
Armstrong World Industries
AWI
$7.38B
| $910K | ﹤0.01% |
4,643
+684
| +17% | +$127K |
|
1093
Appian
APPN
$1.98B
| $905K | ﹤0.01% |
+29,603
| New | +$890K |
|
1094
BW LPG
BWLP
$3.42B
| $901K | ﹤0.01% |
63,061
+16,094
| +34% | +$233K |
|
1095
Keros Therapeutics
KROS
$199M
| $898K | ﹤0.01% |
56,768
+2,891
| +5% | +$42.7K |
|
1096
Sigma Lithium
SGML
$1.11B
| $888K | ﹤0.01% |
+140,520
| New | +$845K |
|
1097
Riot Platforms
RIOT
$7.63B
| $884K | ﹤0.01% |
46,465
+26,520
| +133% | +$367K |
|
1098
FIVE9
FIVN
$2.11B
| $883K | ﹤0.01% |
36,477
+4,849
| +15% | +$128K |
|
1099
Landstar System
LSTR
$5.93B
| $882K | ﹤0.01% |
7,198
+1,461
| +25% | +$194K |
|
1100
ePlus
PLUS
$2.42B
| $882K | ﹤0.01% |
12,418
-6,952
| -36% | -$490K |
|
Similar funds
Mackenzie Financial's Q3 2025 Portfolio in Review
As of Q3 2025, Mackenzie Financial held 1,870 positions worth $82.6B, up 7% from $77.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Mackenzie Financial's Q3 2025 filing shows 171 new, 762 increased, 655 reduced and 171 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 365,000 shares worth $19.5M. The largest sale was Alcon, an estimated $265M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Mackenzie Financial's largest Q3 2025 buy was iShares MSCI Emerging Markets ETF: 365,000 shares worth $19.5M.
- Mackenzie Financial added most to NVIDIA in Q3 2025, an estimated $461M increase.
- Mackenzie Financial's biggest Q3 2025 reduction was Alcon, cutting an estimated $265M.
- Mackenzie Financial fully exited JFrog in Q3 2025, selling an estimated $18.1M.
- Mackenzie Financial's ten largest holdings make up 26% of its $82.6B portfolio in Q3 2025.
- Mackenzie Financial opened 171 new positions and closed 171 in Q3 2025.
- Mackenzie Financial's portfolio value rose 7% quarter-over-quarter to $82.6B.
Based on Mackenzie Financial's 13F filing for Q3 2025, filed 13 Nov 2025.